DB
BME icon

Dmitry Balyasny’s BlackRock Health Sciences Trust BME Stock Holding History

Dmitry Balyasny’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,594
Closed -$386K – 2931
2025
Q2 		$386K Buy
+10,594
New +$384K ﹤0.01% 2393

Other funds holding BME

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dmitry Balyasny's BME Position: Q3 2025 in Review

Dmitry Balyasny sold out of BlackRock Health Sciences Trust (BME) in Q3 2025, closing a stake of 10,594 shares — an estimated $386K sold.

Dmitry Balyasny first reported a position in BME in Q2 2025 and held it in 1 quarter. The position peaked at $386K in Q2 2025. 76 funds tracked by Wall St. Rank hold BME as of Q3 2025.

  • Dmitry Balyasny reported no remaining BlackRock Health Sciences Trust position as of Q3 2025 after selling out during the quarter.
  • Dmitry Balyasny sold 10,594 BlackRock Health Sciences Trust shares in Q3 2025, an estimated $386K.
  • Dmitry Balyasny first reported a position in BlackRock Health Sciences Trust in Q2 2025 and held it in 1 quarter.
  • Dmitry Balyasny's BlackRock Health Sciences Trust position peaked at $386K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.